Category Archives: Prescribing Newsletter

Supply Issues in Primary Care – Update June 2019

The Department of Health & Social Care (DHSC) Medicines Supply team have published the latest supply issues update for primary & secondary care.. The update provides information on new, ongoing and resolved supply issues as well as forthcoming discontinuations – with details of mitigating action taken by manufacturers, regulators & the DHSC, plus signposting to advice on alternatives. Registered users can Continue Reading »

Northern England Clinical Network NOAC Alert Cards – Supplies

Northern England Clinical Network (NECN) Non-Vitamin K Oral Anticoagulant medicines (NOAC) Alert Cards In 2015, NECN Cardiac Rhythm Management subgroup – supported by the Stroke Advisory Group, Haematology Group, Pharmacy Group, Primary Care Group, Thrombosis Group, acute care physicians and patient representation groups – launched a NOAC Alert Card. An initial supply was sent to all NHS Trust Continue Reading »

Valproate – NICE guidance summary

NICE have published a summary of guidance and safety advice on use of valproate in children, young people and adults – including updated recommendations on prescribing for women or girls with childbearing potential: Do not prescribe valproate for any condition, unless there is no other effective or tolerated treatment available, and only if the terms of the pregnancy Continue Reading »

TARGET Antibiotic Toolkit – Refreshed Patient Leaflets

The RCGP TARGET [Treat Antibiotics Responsibly, Guidance, Education & Tools ] Antibiotic Toolkit has been refreshed and updated in recent months. The updated toolkit now includes a comprehensive guide to the available resources with advice and tips on using them in practice. Among the refreshed resources are: new versions of the Treating Your Infection – Respiratory Tract Infection Continue Reading »

Unlicensed Medicines for Children – Use Standard Strengths

The Neonatal and Paediatric Pharmacists’ Group (NPPG) and the Royal College of Paediatrics and Child Health (RCPCH) have issued a joint statement on using standardised strengths of unlicensed liquid medicines in children. The two bodies strongly recommend that when children require unlicensed liquid medications, they should receive the RCPCH- and NPPG- recommended strength, where one exists. There are currently 17 Continue Reading »